Windrose Medical Properties Trust REIT Prices Equity Offering

INDIANAPOLIS, April 12  -- Windrose Medical
Properties Trust (NYSE: WRS), a self-managed specialty medical properties
REIT, announced today it has priced a public offering of 2,300,000 common
shares at $14.80 per share. As part of the offering, Windrose granted its
underwriters a 30-day option to purchase up to an additional 345,000 shares
to cover over-allotments. The net proceeds of the offering, after
underwriting discounts, commissions and estimated offering expenses, and
before giving effect to the over-allotment option, if exercised, will be
approximately $32.3 million. The proceeds will be used to pay down
Windrose's existing indebtedness and for general corporate purposes,
including possible future acquisitions of specialty medical properties.
Robert W. Baird & Co. was sole-book runner and Raymond James &
Associates, Inc. was co-manager.
The closing of the offering is expected to occur on April 18, 2006 and
is subject to customary closing conditions.
Copies of the prospectus supplement relating to the offering may be
obtained by contacting Robert W. Baird & Co. Incorporated, 777 East
Wisconsin Avenue, Milwaukee, WI 53201.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy nor shall there be any sale or an offer to
buy these securities in any state in which such offer, solicitation or sale
would be unlawful prior to registration or qualification under the
securities laws of any such state.
ABOUT WINDROSE
Windrose is a self-managed Real Estate Investment Trust (REIT) based in
Indianapolis, Indiana with offices in Nashville, Tennessee. Windrose was
formed to acquire, selectively develop and manage specialty medical
properties, such as medical office buildings, ambulatory surgery centers,
outpatient treatment and diagnostic facilities and specialty hospitals and
treatment centers.
SAFE HARBOR
Some of the statements in this news release, including those related to
this offering and the use of proceeds, constitute forward-looking
statements. Such statements include, in particular, statements about our
beliefs, expectations, plans and strategies that are not based on
historical facts. You should not rely on our forward-looking statements
because the matters they describe are subject to known and unknown risks,
uncertainties, assumptions and changes in circumstances, many of which are
beyond our control, which may cause our actual results to differ
significantly from those expressed in any forward-looking statement. The
factors that could cause actual results to differ materially from current
expectations include our ability to complete this offering, our ability to
deploy the net proceeds from the offering, changes in economic and general
business conditions and other factors described from time to time in
filings we make with the Securities and Exchange Commission. The
forward-looking statements contained herein represent our judgment as of
the date hereof, and we caution readers not to place undue reliance on such
statements. We do not undertake to publicly update or revise any
forward-looking statement whether as a result of new information, future
events or otherwise.
Contact:
Windrose Medical Properties Trust
Fred Farrar
President and COO
317-860-8213

Investors/Media:
The Ruth Group
Stephanie Carrington/Jason Rando
646 536-7017/7025
scarrington@theruthgroup.com
jrando@theruthgroup.com



SOURCE Windrose Medical Properties Trust